NCT00507793View on ClinicalTrials.gov

Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving Sirolimus

PHASE4CompletedINTERVENTIONAL
Enrollment

385

Participants

Timeline

Start Date

April 30, 2000

Study Completion Date

June 30, 2002

Conditions
Kidney Transplantation
Interventions
DRUG

Sirolimus

DRUG

Cyclosporine

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00507793 - Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving Sirolimus | Biotech Hunter | Biotech Hunter